PKM and colorectal cancer: Recently, mass spectrometry has demonstrated increases in PKM2, and the predominant presence of PKM2 was confirmed in RCC, bladder carcinoma, hepatocellular carcinoma, colorectal cancer, lung carcinoma, and follicular thyroid adenoma [16].